Video

Case 1 Presentation: A 60-Year-Old Woman With Muscle-Invasive Bladder Cancer (MIBC)

Author(s):

Karim Chamie, MD

Karim Chamie, MD, presents the case of a 60-year-old patient with stage 3A muscle-invasive bladder cancer (MIBC) and explains her risk of disease recurrence and whether the case is similar to the patients he typically sees in his clinical practice.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!
Related Videos
DNA helix | Image Credit: © Radomir Jovanovic - stock.adobe.com
Medical stethoscope and dollar bills | Image Credit: © Kuzmick - stock.adobe.com
Daniel D. Joyce, MD, MS, answers a question during a Zoom video interview
Human urinary bladder | Image Credit: © magicmine - stock.adobe.com
Urology Times Mitomycin RX Review Square Thumb
Urology Times Mitomycin RX Review Square Thumb
Urology Times Mitomycin RX Review Square Thumb
Urology Times Mitomycin RX Review Square Thumb
Urology Times Mitomycin RX Review Square Thumb
Related Content
BCAN launches $1 million grant for bladder cancer research impacted by federal funding cuts
July 16th 2025

BCAN launches $1 million grant for bladder cancer research impacted by federal funding cuts

Hannah Clarke
The Continuity Grant will support projects in bladder cancer and/or upper tract urothelial carcinoma that were previously scientifically reviewed, approved, and funded.
medical depiction of bladder cancer
May 31st 2023

Bladder Cancer Awareness Month: Dr. Kamat highlights the state of bladder cancer care

Urology Times staff
In this episode, Ashish M. Kamat, MD, MBBS, highlights the state of bladder cancer care in recognition of Bladder Cancer Awareness Month.
Data support combination intravesical chemotherapy for high-risk NMIBC
July 10th 2025

Data support combination intravesical chemotherapy for high-risk NMIBC

Hannah Clarke
“This study adds to the growing body of evidence supporting combination intravesical chemotherapy as a feasible option even after prior treatment failure," says Ian M. McElree, MD.
Speaking of Urology Podcast: Dr. Ritch and Dr. Katz discuss new bladder cancer management app
December 7th 2021

Speaking of Urology Podcast: Dr. Ritch and Dr. Katz discuss new bladder cancer management app

Urology Times staff
“It's not a replacement for clinical judgment, obviously. But at the end of the day, the idea is that it shows you what your next steps are based on what the American Urological Association and [Society of Urologic Oncology] guidelines are for non-muscle invasive bladder cancer,” Chad R. Ritch, MD, MBA, FACS.
Human urinary system | Image Credit: © magicmine - stock.adobe.com
July 8th 2025

Enrollment complete for phase 3 UTOPIA trial in LG-IR-NMIBC

Benjamin P. Saylor Hannah Clarke
Eligible patients will receive UGN-103 75 mg intravesically once per week for 6 weeks.
Zelenectide pevedotin plus pembrolizumab shows promising anti-tumor activity in mUC
July 8th 2025

Zelenectide pevedotin plus pembrolizumab shows promising anti-tumor activity in mUC

Hannah Clarke
The data, collected as part of the phase 1/2 Duravelo-1 trial, showed an objective response rate of 65%.
© 2025 MJH Life Sciences

All rights reserved.